COVID-19 and cancer (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "COVID-19 and cancer" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2^nd place

2^nd place

2web.archive.org

1^st place

1^st place

1internetmedicin.se

low place

low place

5^th place

5^th place

1england.nhs.uk

low place

low place

1socialstyrelsen.se

low place

low place

low place

low place

low place

low place

doi.org

Dhodapkar M, Dhodapkar K, Ahmed R (January 2021). "Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19". Blood Cancer Discovery. 2 (1): 9–12. doi:10.1158/2643-3230.BCD-20-0177. PMC 8486288. PMID 34604788.
Burki, Talha Khan (1 May 2020). "Cancer guidelines during the COVID-19 pandemic". The Lancet Oncology. 21 (5): 629–630. doi:10.1016/S1470-2045(20)30217-5. ISSN 1470-2045. PMC 7270910. PMID 32247319.
Saini, Geetanjali; Aneja, Ritu (June 2021). "Cancer as a prospective sequela of long COVID-19". BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology. 43 (6): e2000331. doi:10.1002/bies.202000331. PMC 8206711. PMID 33914346.

england.nhs.uk

"Clinical guide for the management of noncoronavirus patients requiring acute treatment: Cancer" (PDF). Archived from the original (PDF) on 29 July 2020. Retrieved 13 May 2020.

esmo.org

"Cancer Care During the COVID-19 Pandemic: An ESMO Guide for Patients". www.esmo.org. Retrieved 13 May 2020.

essoweb.org

"ESSO Statement on COVID-19 :: ESSO". www.essoweb.org. Archived from the original on 5 November 2020. Retrieved 13 May 2020.

internetmedicin.se

"COVID-19 och cancer". www.internetmedicin.se. Retrieved 13 May 2020.

nih.gov

ncbi.nlm.nih.gov

Dhodapkar M, Dhodapkar K, Ahmed R (January 2021). "Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19". Blood Cancer Discovery. 2 (1): 9–12. doi:10.1158/2643-3230.BCD-20-0177. PMC 8486288. PMID 34604788.
Burki, Talha Khan (1 May 2020). "Cancer guidelines during the COVID-19 pandemic". The Lancet Oncology. 21 (5): 629–630. doi:10.1016/S1470-2045(20)30217-5. ISSN 1470-2045. PMC 7270910. PMID 32247319.
Saini, Geetanjali; Aneja, Ritu (June 2021). "Cancer as a prospective sequela of long COVID-19". BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology. 43 (6): e2000331. doi:10.1002/bies.202000331. PMC 8206711. PMID 33914346.

pubmed.ncbi.nlm.nih.gov

Dhodapkar M, Dhodapkar K, Ahmed R (January 2021). "Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19". Blood Cancer Discovery. 2 (1): 9–12. doi:10.1158/2643-3230.BCD-20-0177. PMC 8486288. PMID 34604788.
Burki, Talha Khan (1 May 2020). "Cancer guidelines during the COVID-19 pandemic". The Lancet Oncology. 21 (5): 629–630. doi:10.1016/S1470-2045(20)30217-5. ISSN 1470-2045. PMC 7270910. PMID 32247319.
Saini, Geetanjali; Aneja, Ritu (June 2021). "Cancer as a prospective sequela of long COVID-19". BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology. 43 (6): e2000331. doi:10.1002/bies.202000331. PMC 8206711. PMID 33914346.

socialstyrelsen.se

"Förekomst och utfall av covid-19 hos personer med cancer" (PDF) (in Swedish). Swedish National Board of Health and Welfare. 2020-06-17. Dnr. 5.7-31575/2019. Retrieved 2022-04-02.

web.archive.org

"Clinical guide for the management of noncoronavirus patients requiring acute treatment: Cancer" (PDF). Archived from the original (PDF) on 29 July 2020. Retrieved 13 May 2020.
"ESSO Statement on COVID-19 :: ESSO". www.essoweb.org. Archived from the original on 5 November 2020. Retrieved 13 May 2020.

worldcat.org

search.worldcat.org

Burki, Talha Khan (1 May 2020). "Cancer guidelines during the COVID-19 pandemic". The Lancet Oncology. 21 (5): 629–630. doi:10.1016/S1470-2045(20)30217-5. ISSN 1470-2045. PMC 7270910. PMID 32247319.